Usana Health Sciences PE ratio USNA

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 32.9×; Aug 2026
10-year median: 15.6×
10-year range: 10.5× to 47.0×
Peer median: 18.4×

Usana Health Sciences has no meaningful PE ratio today: it lost $1.21 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Aug 2026, at 32.9×.

On the days it had one over the last ten years, its median was 15.6×, from 10.5× in Apr 2017 to 47.0× in Jul 2026.

PE ratio over time

median 15.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	32.9×	19.7×	47.0×
2025	22.5×	10.5×	23.2×
2024	12.6×	11.8×	16.5×
2023	17.3×	13.7×	20.2×
2022	13.4×	11.1×	15.6×
2021	15.5×	13.4×	18.0×
2020	14.3×	10.8×	19.4×
2019	18.5×	12.1×	33.5×
2018	32.4×	20.3×	45.9×
2017	20.4×	10.5×	20.6×
2016	11.7×	11.5×	19.4×
2015	18.3×	18.2×	26.8×
2014	19.2×	10.7×	22.4×
2013	14.3×	8.5×	17.6×
2012	7.8×	7.8×	13.3×

Against its peers

Companies in Chemicals nearest Usana Health Sciences' size, closest first, today.

Company	PE ratio
USNAUsana Health Sciences	n/m
NAGENiagen Bioscience	13.5×
FTLFFitlife Brands	13.5×
FTKFlotek Industries	24.1×
CRONCronos	16.8×
BTMDbiote	10.7×
ROGRogers	71.4×
NGVTIngevity	47.4×
IOSPInnospec	20.1×
Peer median	18.4×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Usana Health Sciences

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.